NLRP3 and esophageal squamous cell carcinoma: The five-year survival rate and median survival time of patients in the positive group were significantly lower than those in the negative group, suggesting that the effective elimination of Fn and the inhibition of high NLRP3 expression and MDSCs enrichment prolongs the survival of ESCC patients undergoing conventional postoperative TP chemotherapy.